Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

6.40
Delayed Data
As of Feb 24
 -0.14 / -2.14%
Today’s Change
3.50
Today|||52-Week Range
10.89
+19.63%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.54
Today’s open6.59
Day’s range6.40 - 6.59
Volume14,557
Average volume (3 months)14,487
Market cap$509.7M
Dividend yield--
Data as of 02/24/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-540.35%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.05+0.41%
OFIXOrthofix Internation...+0.46+1.23%
CFMSConforMIS Inc+0.21+4.05%
RTIXRTI Surgical Inc+0.10+2.86%
Data as of 4:02pm ET, 02/24/2017

Financials

Last reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts


Search for Jobs